Cidara Therapeutics
CDTX
CDTX
45 hedge funds and large institutions have $26.6M invested in Cidara Therapeutics in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
38% less capital invested
Capital invested by funds: $42.5M → $26.6M (-$16M)
47% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 15
Holders
45
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.86M | |
| 2 | +$1.58M | |
| 3 | +$360K | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$233K |
| 5 |
DMK
David M. Knott
|
+$216K |
Top Sellers
| 1 | -$2.65M | |
| 2 | -$418K | |
| 3 | -$257K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$254K |
| 5 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$249K |